VWM
TFFP

Venturi Wealth Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Venturi Wealth Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-330
Closed -$2.32K – 1458
2023
Q4 		$2.32K Sell
330
-1
-0.3% -$8 ﹤0.01% 1182
2023
Q3 		$2.9K Buy
+331
New +$3.1K ﹤0.01% 1094
2023
Q2 		– Sell
-405
Closed -$6.95K – 1308
2023
Q1 		$6.95K Buy
+405
New +$8.77K ﹤0.01% 767
2022
Q4 		– Sell
-331
Closed -$34K – 357
2022
Q3 		$34K Buy
+331
New +$44.8K ﹤0.01% 309
2021
Q3 		– Sell
-331
Closed -$80K – 339
2021
Q2 		$80K Buy
+331
New +$90.8K 0.01% 302
2021
Q1 		– Sell
-331
Closed -$118K – 339
2020
Q4 		$118K Buy
+331
New +$127K 0.01% 297

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Venturi Wealth Management's TFFP Position: Q1 2024 in Review

Venturi Wealth Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2024, closing a stake of 330 shares — an estimated $2.32K sold.

Venturi Wealth Management first reported a position in TFFP in Q4 2020 and held it in 6 quarters. The position peaked at $118K in Q4 2020. 19 funds tracked by Wall St. Rank hold TFFP as of Q1 2024.

  • Venturi Wealth Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Venturi Wealth Management sold 330 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $2.32K.
  • Venturi Wealth Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Venturi Wealth Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $118K in Q4 2020.
  • 19 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Venturi Wealth Management's 13F filing for Q1 2024, filed 23 Apr 2024.